SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-059064
Filing Date
2024-05-14
Accepted
2024-05-14 06:30:34
Documents
72
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sybx-20240331.htm   iXBRL 10-Q 1778288
2 EX-10.1 sybx-ex10_1.htm EX-10.1 39117
3 EX-31.1 sybx-ex31_1.htm EX-31.1 13216
4 EX-31.2 sybx-ex31_2.htm EX-31.2 13248
5 EX-32.1 sybx-ex32_1.htm EX-32.1 7104
6 EX-32.2 sybx-ex32_2.htm EX-32.2 7021
7 GRAPHIC img121608722_0.jpg GRAPHIC 70319
8 GRAPHIC img138293864_0.jpg GRAPHIC 4791
9 GRAPHIC img138293864_1.jpg GRAPHIC 8251
  Complete submission text file 0000950170-24-059064.txt   6739494

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sybx-20240331.xsd EX-101.SCH 990315
75 EXTRACTED XBRL INSTANCE DOCUMENT sybx-20240331_htm.xml XML 911319
Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37566 | Film No.: 24941365
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)